[go: up one dir, main page]

Kataoka-Hamai et al., 2020 - Google Patents

Determination of the Coverage of Phosphatidylcholine Monolayers Formed at Silicone Oil–Water Interfaces by Vesicle Fusion

Kataoka-Hamai et al., 2020

Document ID
8862644166851386158
Author
Kataoka-Hamai C
Kawakami K
Publication year
Publication venue
The Journal of Physical Chemistry B

External Links

Snippet

Phospholipid monolayers at oil–water interfaces are used for various biological applications and often formed by vesicle adsorption. However, the adsorbed structures are not well characterized; therefore, fundamental investigation on vesicle adsorption behavior is …
Continue reading at pubs.acs.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension

Similar Documents

Publication Publication Date Title
Richards et al. Membrane protein mobility and orientation preserved in supported bilayers created directly from cell plasma membrane blebs
Jurak Thermodynamic aspects of cholesterol effect on properties of phospholipid monolayers: Langmuir and Langmuir–Blodgett monolayer study
Okur et al. Chemistry of lipid membranes from models to living systems: a perspective of hydration, surface potential, curvature, confinement and heterogeneity
Nicolini et al. Visualizing association of N-Ras in lipid microdomains: influence of domain structure and interfacial adsorption
Tabaei et al. Formation of cholesterol-rich supported membranes using solvent-assisted lipid self-assembly
Balaz Modeling kinetics of subcellular disposition of chemicals
Yilmaz et al. Visualization of lipid membrane reorganization induced by a pore-forming toxin using high-speed atomic force microscopy
Taylor et al. Capacitive detection of low-enthalpy, higher-order phase transitions in synthetic and natural composition lipid membranes
Mattei et al. Solubilization of binary lipid mixtures by the detergent Triton X-100: the role of cholesterol
Simonsson et al. Continuous lipid bilayers derived from cell membranes for spatial molecular manipulation
Pedrera et al. The presence of sterols favors sticholysin I-membrane association and pore formation regardless of their ability to form laterally segregated domains
Morandat et al. Membrane resistance to Triton X-100 explored by real-time atomic force microscopy
Makky et al. Impact of lipid oxidization on biophysical properties of model cell membranes
Seiwert et al. The nonbilayer lipid MGDG and the major light-harvesting complex (LHCII) promote membrane stacking in supported lipid bilayers
Jiang et al. In situ visualization of lipid raft domains by fluorescent glycol chitosan derivatives
Wood et al. Ibuprofen and the phosphatidylcholine bilayer: membrane water permeability in the presence and absence of cholesterol
Basham et al. Nanoparticle-induced disorder at complex liquid–liquid interfaces: Effects of curvature and compositional synergy on functional surfaces
Bordovsky et al. Engineering lipid structure for recognition of the liquid ordered membrane phase
Berselli et al. Microcavity-supported lipid membranes: versatile platforms for building asymmetric lipid bilayers and for protein recognition
Lee et al. Lipid bilayer disruption by amphiphilic Janus nanoparticles: the role of Janus balance
Liu et al. Headgroup-inversed liposomes: Biointerfaces, supported bilayers and applications
Simonsson et al. Formation and diffusivity characterization of supported lipid bilayers with complex lipid compositions
Via et al. Negative dipole potentials and carboxylic polar head groups foster the insertion of cell-penetrating peptides into lipid monolayers
Sybachin et al. Composition and properties of complexes between spherical polycationic brushes and anionic liposomes
Kataoka-Hamai et al. Determination of the Coverage of Phosphatidylcholine Monolayers Formed at Silicone Oil–Water Interfaces by Vesicle Fusion